Bioreductive metabolism of AF-2 [2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide] combined with 2-nitroimidazoles: Implications for use as hypoxic cell markers
Open Access
- 14 September 1993
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 46 (6), 1029-1036
- https://doi.org/10.1016/0006-2952(93)90667-l
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Keynote address: Cellular reduction of nitroimidazole drugs: Potential for selective chemotherapy and diagnosis of hypoxic cellsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- A novel technique for measuring human tissue pO2 at the cellular levelBritish Journal of Cancer, 1986
- Covalent binding of a fluorinated 2-nitroimidazole to emt-6 tumors in Balb/C mice: detection by f-19 nuclear magnetic resonance at 2.35 TInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Oxygen tension in human tumors: in vivo mapping using CT-guided probes.Radiology, 1985
- Heterogeneous Oxygenation of Rectal Carcinomas in Humans: A Critical Parameter for Preoperative Irradiation?Published by Springer Nature ,1984
- Hypoxia-mediated druGS FOR RADIATION AND CHEMOTHERAPYCancer, 1981
- Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitroBritish Journal of Cancer, 1980
- The hypoxic tumor cell: A target for selective cancer chemotherapyBiochemical Pharmacology, 1980
- Hypoxic Sensitizers — Implications for Radiation TherapyNew England Journal of Medicine, 1979
- The Histological Structure of Some Human Lung Cancers and the Possible Implications for RadiotherapyBritish Journal of Cancer, 1955